Evidence map›Paper›PMID 35189927›Full record

ArticleOrphanet journal of rare diseases2022

Transition from child to adult health care for patients with lysosomal storage diseases in France: current status and priorities-the TENALYS study, a patient perspective survey.

Delphine Genevaz, Armelle Arnoux, Catherine Marcel, Anaïs Brassier, Samia Pichard, François Feillet, François Labarthe, Brigitte Chabrol, Marc Berger, Anne-Sophie Lapointe and 4 more

Open access · goldAbstract read
In one paragraph

Article in Orphanet journal of rare diseases, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
5.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Observational
  11. Review
  12. Article
  13. Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 8 institutions in 1 country.

Delphine GenevazVaincre les Maladies Lysosomales (VML), Massy, France.
Armelle ArnouxClinical Investigational Center 14-18, Clinical Epidemiology INSERM & Clinical Research Unit, Assistance Publique-Hôpitaux de Paris Centre, Paris University & European Hospital Georges Pompidou, Paris, France.
Catherine MarcelReference Center for Lysosomal Diseases, Assistance-Publique Hôpitaux de Paris, Beaujon Hospital, Paris University, Paris, France.
Anaïs BrassierReference Center for Inherited Metabolic Diseases, Assistance Publique-Hôpitaux de Paris, Necker Hospital, Paris University, Paris, France.
Samia PichardReference Center for Inherited Metabolic Diseases, Assistance Publique-Hôpitaux de Paris, Necker Hospital, Paris University, Paris, France.
François FeilletReference Center for Inherited Metabolic Diseases, Nancy University Hospital, Vandoeuvre-lès-Nancy, France.
François LabartheReference Center for Inherited Metabolic Diseases, Clocheville Hospital, University Hospital, Tours, France.
Brigitte ChabrolReference Center for Inherited Metabolic Diseases, Assistance Publique-Hôpitaux de Marseille, University Hospital of Marseille, Marseille, France.
Marc BergerReference Center for Lysosomal Diseases, Estaing University Hospital, Clermont Ferrand, France.
Anne-Sophie LapointeVaincre les Maladies Lysosomales (VML), Massy, France.
Yvann FrigoutClinical Investigational Center 14-18, Clinical Epidemiology INSERM & Clinical Research Unit, Assistance Publique-Hôpitaux de Paris Centre, Paris University & European Hospital Georges Pompidou, Paris, France.
Bénédicte HéronReference Center for Lysosomal Diseases, Assistance Publique-Hôpitaux de Paris, Trousseau Hospital, Sorbonne University, Paris, France.
Gilles ChatellierClinical Investigational Center 14-18, Clinical Epidemiology INSERM & Clinical Research Unit, Assistance Publique-Hôpitaux de Paris Centre, Paris University & European Hospital Georges Pompidou, Paris, France.
Nadia BelmatougReference Center for Lysosomal Diseases, Assistance-Publique Hôpitaux de Paris, Beaujon Hospital, Paris University, Paris, France. nadia.belmatoug@aphp.fr.ORCID 0000-0002-7917-741X
Inserm · FRAssistance Publique – Hôpitaux de Paris · FRHôpital Beaujon · FRVaincre la Mucoviscidose · FRAssistance Publique Hôpitaux de Marseille · FRCentre Hospitalier Universitaire de Clermont-Ferrand · FRCentre Hospitalier Universitaire de Tours · FRSorbonne Université · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTransition from childhood to adulthood (TCA) is usually difficult in rare, progressive and multisystemic diseases. New treatments and modalities of care for many lysosomal diseases (LD) can increase life expectancy, and a successful TCA can help patient who reach adulthood to avoid disruption to health care. In France, some TCA initiatives have been taken by referral centers but in view of the problems encountered by Vaincre les Maladies Lysosomales (VML), the LD patient association, they seem to be insufficient. The aim of this study is to determine the current state of the TCA process and to identify actions to improve it through interviews with patient families and physicians in LD referral centers. The study is based upon an observational, non-interventional, cross-sectional, national survey which used two anonymous questionnaires. These questionnaires, developed by a scientific committee including representatives from VML and medical specialists in LD, were sent to patients who were receiving care in pediatric departments at age 15 years or older. Questionnaires were also sent to their referral pediatricians.

resultsFifty-four patients were included. Forty-two questionnaires were completed by patients and their corresponding physicians and 12 were completed by physicians only. The majority of the patients (80%) were informed that transfer to adult healthcare would occur, but 52% were informed after their eighteenth birthday. Forty-eight percent indicated that they were informed that a TCA coordinator would be appointed; for 39% the time frame for the transfer was communicated, and 31% were informed of the composition of the adult medical team. Among the actions that patients rated as "important/very important", and considered to be a priority in their comments, the most frequently cited were the provision of explanatory documents on the TCA (94%), the transmission of the medical file from the pediatric sector to the adult sector (94%) and a joint consultation with both pediatrician and adult unit physician (91%). Physicians were in agreement concerning the primary importance of the last two actions.

conclusionThis study provides a basis for the deployment, on the national level, of transition programs which include specific actions that patients view as priorities.

Indexed as

Delivery of Health CareLysosomal Storage DiseasesAdolescentAdultChildCross-Sectional StudiesFranceHumansSurveys and QuestionnairesYoung AdultLysosomal diseasesPatient opinionPatient surveyTransition from childhood to adulthood

Identifiers

PMID35189927
PMCPMC8862388
OpenAlexW4212826100

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.